Johns Hopkins Oncology Center

Baltimore, Maryland 21287-8963

0 studies enrolling now · 110 studies all time

What they study most

Acute Myeloid Leukemia, Anemia, Hemolytic, Autoimmune, Antiphospholipid Antibody Syndrome, Aplastic Anemia, Autoimmune Diseases, B-Cell Acute Lymphoblastic Leukemia, Bladder Cancer, Brain Tumors, Brain and Central Nervous System Tumors, Breast Cancer, Carcinoma of Unknown Primary, Cardiac Toxicity

Studies at this site

• Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients — Running, not enrolling
• Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer — Completed
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
• Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas — Stopped early
• Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed
• Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia — Completed
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer — Completed
• Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer — Completed
• Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer — Completed
• Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer — Completed
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma — Completed
• Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus — Completed
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas — Completed
• Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients — Completed
• Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer — Completed
• An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha — Completed
• Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia — Completed
• External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer — Completed
• Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases — Completed
• Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy — Completed
• CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy — Stopped early
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors — Completed
• Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer — Completed
• Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality — Completed
• MRI to Detect Breast Tumors in Women — Completed
• Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma — Completed
• Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer — Completed
• Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria — Completed
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer — Completed
• Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas — Completed
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
• Talc in Treating Patients With Malignant Pleural Effusion — Completed
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer — Completed
• Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis — Completed
• Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer — Completed
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma — Completed
• Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma — Completed
• Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma — Completed
• Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease — Completed
• Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers — Completed
• Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia — Completed
• Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer — Completed
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer — Completed
• Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia — Completed
• Ecteinascidin 743 in Treating Children With Refractory Solid Tumors — Completed
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer — Completed
• Brachytherapy in Treating Patients With Prostate Cancer — Completed